Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor

被引:194
作者
Yoshida, A [1 ]
AnandApte, B [1 ]
Zetter, BR [1 ]
机构
[1] CHILDRENS HOSP, DEPT SURG, BOSTON, MA 02115 USA
关键词
angiogenesis; endothelium; chemotaxis; chemokinesis; proliferation;
D O I
10.3109/08977199609034566
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neovascularization is a feature of a variety of pathological processes. We compared the characteristics of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) on migration and proliferation of human umbilical vein endothelium (HUVEC). Both VEGF and bFGF induced endothelial cell migration at similar concentrations (1/2 max. VEGF = similar to 1.0 ng/ml, bFGF = similar to 5.0 ng/ml). However, VEGF-stimulated migration was two-fold greater than bFGF at 1 and 10 ng/ml (rho < 0.05). In contrast, bFGF induced proliferation four-fold more effectively than VEGF (1/2 max. 1 ng/ml and 1.4 ng/ml respectively). Checkerboard migration assays for bFGF showed a predominantly chemokinetic pattern, whereas VEGF was predominantly chemotactic. VEGF and bFGF were not synergistic in monolayer proliferation and migration assays. Three angiogenesis inhibitors, alpha-interferon, TNP-470, and platelet factor-4, inhibited VEGF and bFGF induced cell migration. These results indicate that VEGF and bFGF are chemoattractants that stimulate endothelial migration by different mechanisms and that both can be inhibited by known angiogenesis inhibitors.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 33 条
  • [1] [Anonymous], 1995, The molecular basis of cancer
  • [2] MIGRATION AND PROLIFERATION OF ENDOTHELIAL CELLS IN PREFORMED AND NEWLY FORMED BLOOD-VESSELS DURING TUMOR ANGIOGENESIS
    AUSPRUNK, DH
    FOLKMAN, J
    [J]. MICROVASCULAR RESEARCH, 1977, 14 (01) : 53 - 65
  • [3] DIFFERENTIAL EXPRESSION OF THE 2 VEGF RECEPTORS FLT AND KDR IN PLACENTA AND VASCULAR ENDOTHELIAL-CELLS
    BARLEON, B
    HAUSER, S
    SCHOLLMANN, C
    WEINDEL, K
    MARME, D
    YAYON, A
    WEICH, HA
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 54 (01) : 56 - 66
  • [4] TUMOR INTERACTIONS WITH THE VASCULATURE - ANGIOGENESIS AND TUMOR-METASTASIS
    BLOOD, CH
    ZETTER, BR
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) : 89 - 118
  • [6] BREM H, 1991, Surgical Forum (Chicago), V42, P439
  • [7] THE COMBINATION OF ANTIANGIOGENIC AGENTS TO INHIBIT PRIMARY TUMOR-GROWTH AND METASTASIS
    BREM, H
    GRESSER, I
    GROSFELD, J
    FOLKMAN, J
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (10) : 1253 - 1257
  • [8] ANALYSIS OF EXPERIMENTAL ANTIANGIOGENIC THERAPY
    BREM, H
    FOLKMAN, J
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1993, 28 (03) : 445 - 451
  • [9] BROWN LF, 1993, AM J PATHOL, V143, P1255
  • [10] VASCULAR-PERMEABILITY FACTOR - A TUMOR-DERIVED POLYPEPTIDE THAT INDUCES ENDOTHELIAL-CELL AND MONOCYTE PROCOAGULANT ACTIVITY, AND PROMOTES MONOCYTE MIGRATION
    CLAUSS, M
    GERLACH, M
    GERLACH, H
    BRETT, J
    WANG, F
    FAMILLETTI, PC
    PAN, YCE
    OLANDER, JV
    CONNOLLY, DT
    STERN, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) : 1535 - 1545